Drug intelligence / Profile preview

Pentavite

Development stage
Unknown
Lead developer
Pentavite
Modality
Small Molecules
Administration
Oral
01

Overview

Pentavite is an established, commercially available pediatric oral liquid multivitamin supplement widely used in Australia for infants and young children aged 0 to 3 years. The formulation contains a combination of essential vitamins, including Vitamin D3 (colecalciferol), Vitamin A (retinol palmitate), Vitamin C (calcium ascorbate dihydrate), and various B-complex vitamins (thiamine, riboflavin, nicotinamide, and pyridoxine). It acts primarily by targeting the Vitamin D receptor (VDR) and other nutrient-specific pathways to support calcium and phosphate absorption, bone mineralization, immune function, and general growth and development. Pentavite is indicated for the prevention and treatment of vitamin deficiencies, particularly Vitamin D deficiency, in at-risk infants such as preterm infants or those with inadequate sun exposure. In clinical research, it has been utilized as a daily oral comparator against single-dose vitamin D3 regimens in breastfed infants of vitamin D-deficient mothers.

Brand names
PentavitePentavite Multivitamin Liquid for InfantsPentavite Infant Liquid 0-3 years
Other names
Penta-Vite
02

Targets

VDR (Vitamin D receptor)RAR (Retinoic acid receptor)

Beyond the preview

Go deeper on Pentavite.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pentavite.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call